QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.105.005280v1 34/2/296    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, J.-H. Articles by Chung, J.-G. Search for Related Content PubMed PubMed Citation Articles by Yang, J.-H. Articles by Chung, J.-G.

INHIBITION OF LUNG CANCER CELL GROWTH BY QUERCETIN GLUCURONIDES VIA G₂/M ARREST AND INDUCTION OF APOPTOSIS

Department of Dermatology (J.-H.Y.), Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Internal Medicine (T.-C.H.), China Medical University Hospital, Taichung, Taiwan; Departments of Parasitology (H.-M.K.) and Pharmacy (P.-D.L.C.), China Medical University, Taichung, Taiwan; Department of Veterinary Medicine (C.-C.C.), National Chung-Hsin University, Taichung, Taiwan; Department of Biochemistry (Y.H.-W.), National Yang-Ming University, Taipei, Taiwan; and School of Biological Science and Technology (J.-G.C.), China Medical University, Taichung, Taiwan, Republic of China

Lung cancer is the leading cause of cancer death in many developed countries, including Taiwan. Quercetin, a widely distributed bioflavonoid, is well known to induce growth inhibition in a variety of human cancer cells. Quercetin glucuronides are the main circulating metabolites after dietary supplements with quercetin in humans. However, there is little information available as to how quercetin glucuronides affect human cancer cells. We investigated the effects of quercetin glucuronides in a human lung cancer cell line NCI-H209. We checked the cell viability, cell cycle checkpoint proteins, pro- and antiapoptotic proteins, caspase-3 activity, and gene expression by flow cytometry and Western blot. The viability of cells decreased in a dose- and time-dependent manner. Cell cycle analysis revealed a significant increase of the proportion of cells in G₂/M phase and subG₀/G₁ phase (corresponding to apoptotic cells). Moreover, quercetin glucuronides increased the expressions of cyclin B, Cdc25c-ser-216-p, and Wee1 proteins, indicating the G₂/M arrest. We also demonstrated a concurrent decrease of the mitochondrial membrane potential, release of cytochrome c, up-regulation of Bax, down-regulation of Bcl-2, and activation of caspase-3, and subsequently, cleavage of poly(ADP-ribose) polymerase. In addition, quercetin glucuronide-induced apoptosis was totally blocked by the broad-spectrum caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoromethylketone. Taken together, we demonstrated that quercetin glucuronides inhibited proliferation through G₂/M arrest of the cell cycle and induced apoptosis via caspase-3 cascade in the human lung cancer cell line NCI-H209. Delineation of the biological effects of specific major quercetin metabolites on chemotherapeutic potential or chemoprevention of human cancers warrants further investigation.

This article has been cited by other articles:

				C.-S. Shia, Y.-C. Hou, S.-H. Juang, S.-Y. Tsai, P.-H. Hsieh, L.-C. Ho, and P.-D. L. Chao Metabolism and Pharmacokinetics of San-Huang-Xie-Xin-Tang, a Polyphenol-rich Chinese Medicine Formula, in Rats and Ex-vivo Antioxidant Activity Evid. Based Complement. Altern. Med., September 8, 2009; (2009) nep124v1. [Abstract] [Full Text] [PDF]

				S.-Y. Chien, Y.-C. Wu, J.-G. Chung, J.-S. Yang, H.-F. Lu, M.-F. Tsou, W. Wood, S.-J. Kuo, and D.-R. Chen Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells Human and Experimental Toxicology, August 1, 2009; 28(8): 493 - 503. [Abstract] [PDF]

				F.-T. Liu, S. G. Agrawal, Z. Movasaghi, P. B. Wyatt, I. U. Rehman, J. G. Gribben, A. C. Newland, and L. Jia Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib Blood, November 1, 2008; 112(9): 3835 - 3846. [Abstract] [Full Text] [PDF]

				G. D. Stoner, L.-S. Wang, and B. C. Casto Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries Carcinogenesis, September 1, 2008; 29(9): 1665 - 1674. [Abstract] [Full Text] [PDF]